Literature DB >> 25941788

Prostate cancer: Can image-guided biopsy findings evaluate risk of ECE?

Daniel Portalez1, Bernard Malavaud2.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25941788     DOI： 10.1038/nrurol.2015.86

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  9 in total

1.  Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: recommendations from an International Working Group.

Authors:  Caroline M Moore; Veeru Kasivisvanathan; Scott Eggener; Mark Emberton; Jurgen J Fütterer; Inderbir S Gill; Robert L Grubb Iii; Boris Hadaschik; Laurence Klotz; Daniel J A Margolis; Leonard S Marks; Jonathan Melamed; Aytekin Oto; Suzanne L Palmer; Peter Pinto; Philippe Puech; Shonit Punwani; Andrew B Rosenkrantz; Ivo G Schoots; Richard Simon; Samir S Taneja; Baris Turkbey; Osamu Ukimura; Jan van der Meulen; Arnauld Villers; Yuji Watanabe
Journal:  Eur Urol       Date:  2013-03-20       Impact factor: 20.096

2.  The Role of Magnetic Resonance Image Guided Prostate Biopsy in Stratifying Men for Risk of Extracapsular Extension at Radical Prostatectomy.

Authors:  Dima Raskolnikov; Arvin K George; Soroush Rais-Bahrami; Baris Turkbey; M Minhaj Siddiqui; Nabeel A Shakir; Chinonyerem Okoro; Jason T Rothwax; Annerleim Walton-Diaz; Sandeep Sankineni; Daniel Su; Lambros Stamatakis; Maria J Merino; Peter L Choyke; Bradford J Wood; Peter A Pinto
Journal:  J Urol       Date:  2015-01-23       Impact factor: 7.450

3.  Prostate Imaging Reporting and Data System and Likert Scoring System: Multiparametric MR Imaging Validation Study to Screen Patients for Initial Biopsy.

Authors:  Raphaëlle Renard-Penna; Pierre Mozer; François Cornud; Nicolas Barry-Delongchamps; Eric Bruguière; Daniel Portalez; Bernard Malavaud
Journal:  Radiology       Date:  2015-01-19       Impact factor: 11.105

4.  The predictive value of endorectal 3 Tesla multiparametric magnetic resonance imaging for extraprostatic extension in patients with low, intermediate and high risk prostate cancer.

Authors:  D M Somford; E H Hamoen; J J Fütterer; J P van Basten; C A Hulsbergen-van de Kaa; W Vreuls; I M van Oort; H Vergunst; L A Kiemeney; J O Barentsz; J A Witjes
Journal:  J Urol       Date:  2013-05-13       Impact factor: 7.450

Review 5.  TRUS-MRI image registration: a paradigm shift in the diagnosis of significant prostate cancer.

Authors:  F Cornud; L Brolis; N Barry Delongchamps; D Portalez; B Malavaud; R Renard-Penna; P Mozer
Journal:  Abdom Imaging       Date:  2013-12

6.  Quantitative biopsy pathology for the prediction of pathologically organ-confined prostate carcinoma: a multiinstitutional validation study.

Authors:  Alexander Haese; Manisha Chaudhari; M Craig Miller; Jonathan I Epstein; Hartwig Huland; Juri Palisaar; Markus Graefen; Peter Hammerer; Edward C Poole; Gerard J O'Dowd; Alan W Partin; Robert W Veltri
Journal:  Cancer       Date:  2003-02-15       Impact factor: 6.860

7.  Magnetic resonance imaging-transectal ultrasound image-fusion biopsies accurately characterize the index tumor: correlation with step-sectioned radical prostatectomy specimens in 135 patients.

Authors:  Eduard Baco; Osamu Ukimura; Erik Rud; Ljiljana Vlatkovic; Aud Svindland; Manju Aron; Suzanne Palmer; Toru Matsugasumi; Arnaud Marien; Jean-Christophe Bernhard; John C Rewcastle; Heidi B Eggesbø; Inderbir S Gill
Journal:  Eur Urol       Date:  2014-09-17       Impact factor: 20.096

8.  Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting.

Authors:  Louise Dickinson; Hashim U Ahmed; Clare Allen; Jelle O Barentsz; Brendan Carey; Jurgen J Futterer; Stijn W Heijmink; Peter J Hoskin; Alex Kirkham; Anwar R Padhani; Raj Persad; Philippe Puech; Shonit Punwani; Aslam S Sohaib; Bertrand Tombal; Arnauld Villers; Jan van der Meulen; Mark Emberton
Journal:  Eur Urol       Date:  2010-12-21       Impact factor: 20.096

9.  ESUR prostate MR guidelines 2012.

Authors:  Jelle O Barentsz; Jonathan Richenberg; Richard Clements; Peter Choyke; Sadhna Verma; Geert Villeirs; Olivier Rouviere; Vibeke Logager; Jurgen J Fütterer
Journal:  Eur Radiol       Date:  2012-02-10       Impact factor: 5.315
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.